• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Brooks Automation, Inc. filed SEC Form 8-K: Leadership Update, Other Events, Financial Statements and Exhibits

    10/7/21 4:10:04 PM ET
    $BRKS
    Industrial Machinery/Components
    Technology
    Get the next $BRKS alert in real time by email
    brks_20190618_8K
    0000933974false00009339742021-10-042021-10-04

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

    FORM 8-K

    CURRENT REPORT

    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

    Date of Report (Date of earliest event reported): October 4, 2021

    BROOKS AUTOMATION, INC.

    (Exact Name of Registrant as Specified in Charter)

    Delaware

        

    0-25434

        

    04-3040660

    (State or Other Jurisdiction of Incorporation)

     

    (Commission File Number)

     

    (IRS Employer Identification No.)

    ​

    ​

    15 Elizabeth Drive, Chelmsford, MA

     

    01824

    (Address of Principal Executive Offices)

     

    (Zip Code)

    ​

    Registrant's telephone number, including area code: (978) 262-2400

    N/A

    (Former name or former address, if changed since last report.)

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

    ☐    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

    ☐    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

    ☐    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

    ☐    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:

    Title of each class

    Trading Symbol(s)

    Name of each exchange on which registered

    Common Stock, $0.01 par value

    BRKS

    The Nasdaq Stock Market LLC

    ​

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b- 2 of this chapter).

    Emerging growth company  ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

    ​

    ​

    Item 5.02.

    Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

    (b) and (e) On October 4, 2021, Brooks Automation, Inc. (“Brooks”) and Guojuan (Amy) Liao agreed that Dr. Liao will no longer serve as President, Life Sciences Services effective as of October 11, 2021. In addition, on October 4, 2021, Brooks and Dr. Liao entered into a letter agreement under which Dr. Liao will serve as a strategic advisor to Stephen S. Schwartz, Brooks’ President and Chief Executive Officer, from October 11, 2021 through December 31, 2021. Under the letter agreement, Dr. Liao will be compensated at a rate equal to 62.5% of her current base salary, reflecting a 25-hour work week while serving in the role of strategic advisor.

    ​

    Item 8.01.Other Events.

    ​

    On October 7, 2021, Brooks issued a press release announcing the transition and pending departure of Dr. Liao. A copy of the press release has been filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

    ​

    Item 9.01.Financial Statements and Exhibits.

    ​

    (d) Exhibits

    ​

    99.1

    Press Release dated October 7, 2021, issued by Brooks Automation, Inc.

    104

    Cover Page Interactive Data File (embedded within the iXBRL (Inline eXtensible Business Reporting Language) document).

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    SIGNATURE

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

    ​

    ​

    ​

    BROOKS AUTOMATION, INC.

    ​

    ​

    Date: October 7, 2021

    /s/ Jason W. Joseph

    ​

    Jason W. Joseph

    ​

    Senior Vice President, General Counsel and Secretary

    ​

    ​

    Get the next $BRKS alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $BRKS

    DatePrice TargetRatingAnalyst
    11/17/2021$139.00 → $155.00Buy
    Needham
    11/17/2021$146.00 → $132.00Overweight
    Keybanc
    11/11/2021$100.00 → $120.00Neutral
    Citigroup
    11/10/2021$121.00 → $139.00Buy
    Needham
    9/7/2021$115.00 → $146.00Overweight
    Keybanc
    8/6/2021$130.00 → $114.00Buy
    Needham
    More analyst ratings

    $BRKS
    Leadership Updates

    Live Leadership Updates

    See more
    • Azenta Life Sciences Names Matthew McManus Chief Operating Officer

      CHELMSFORD, Mass., Jan. 6, 2022 /PRNewswire/ -- Azenta, Inc. (NASDAQ:AZTA) today announced that it has appointed Matthew McManus Chief Operating Officer effective January 17th.  In this newly created role, Dr. McManus will oversee Life Sciences Products, Services, and all commercial operations of the business and will report directly to the CEO. "We are excited to have Matt join the Company as our COO," said Steve Schwartz, President and CEO of Azenta. "Matt brings decades of expertise in life sciences. His depth of knowledge and valuable perspective will enhance our leadership position in the markets we serve." Dr. McManus joins Azenta with over 25 years of experience in the life s

      1/6/22 4:05:00 PM ET
      $AZTA
      $BRKS
      Industrial Machinery/Components
      Technology

    $BRKS
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Azenta Announces Fiscal 2022 Fourth Quarter and Full Year Earnings Conference Call and Webcast

      CHELMSFORD, Mass., Nov. 7, 2022 /PRNewswire/ -- Azenta, Inc. (NASDAQ:AZTA) will announce fiscal fourth quarter and full year 2022 earnings which ended on September 30, 2022 on Monday, November 14, 2022 after the market closes. The Company will host a conference call and live webcast to discuss its financial results on the same day, Monday, November 14, 2022 at 4:30 p.m. Eastern Time.  To participate in the conference call, please dial 800-936-4761 for domestic callers and +1-212-231-2922 for international callers. Analysts, investors and members of the media can access the live webcast via the Azenta website at https://investors.azenta.com/events.  A replay will be available beginning at 8:3

      11/7/22 4:38:00 PM ET
      $AZTA
      $BRKS
      Industrial Machinery/Components
      Technology
    • Azenta Announces Completion of B Medical Systems Acquisition

      CHELMSFORD, Mass., Oct. 3, 2022 /PRNewswire/ -- Azenta, Inc. (NASDAQ:AZTA) today announced that it has closed its previously announced acquisition of B Medical Systems S.á r.l and its subsidiaries ("B Medical"), a market leader in temperature-controlled storage and transportation solutions that enables the delivery of life-saving treatments to more than 150 countries worldwide. This acquisition complements Azenta's cold chain capabilities, adding differentiated solutions for reliable and traceable transport of temperature-sensitive specimens. B Medical, headquartered in Hosingen, Luxembourg, is one of the leading vaccine cold chain providers serving primarily fast-growing emerging markets, w

      10/3/22 4:05:00 PM ET
      $AZTA
      $BRKS
      Industrial Machinery/Components
      Technology
    • Azenta to Participate in the Baird 2022 Global Healthcare Conference

      CHELMSFORD, Mass., Sept. 6, 2022 /PRNewswire/ -- Azenta, Inc. (NASDAQ:AZTA) today announced that Company management will participate in the Baird 2022 Global Healthcare Conference in New York City, on Wednesday, September 14, 2022, which includes a presentation beginning at 9:40 am ET. The live webcast can be accessed through the Azenta investor relations website at https://investors.azenta.com/events. A replay of the webcast will be available following the event. About Azenta Life Sciences Azenta, Inc. (NASDAQ:AZTA) is a leading provider of life sciences solutions worldwide, enabling impactful breakthroughs and therapies to market faster. Azenta provides a full suite of reliable cold-chain

      9/6/22 4:05:00 PM ET
      $AZTA
      $BRKS
      Industrial Machinery/Components
      Technology

    $BRKS
    Financials

    Live finance-specific insights

    See more
    • Azenta Announces Fiscal 2022 Fourth Quarter and Full Year Earnings Conference Call and Webcast

      CHELMSFORD, Mass., Nov. 7, 2022 /PRNewswire/ -- Azenta, Inc. (NASDAQ:AZTA) will announce fiscal fourth quarter and full year 2022 earnings which ended on September 30, 2022 on Monday, November 14, 2022 after the market closes. The Company will host a conference call and live webcast to discuss its financial results on the same day, Monday, November 14, 2022 at 4:30 p.m. Eastern Time.  To participate in the conference call, please dial 800-936-4761 for domestic callers and +1-212-231-2922 for international callers. Analysts, investors and members of the media can access the live webcast via the Azenta website at https://investors.azenta.com/events.  A replay will be available beginning at 8:3

      11/7/22 4:38:00 PM ET
      $AZTA
      $BRKS
      Industrial Machinery/Components
      Technology
    • Azenta Life Sciences Reports Results of Third Quarter of Fiscal 2022, Ended June 30, 2022

      CHELMSFORD, Mass., Aug. 9, 2022 /PRNewswire/ -- Azenta, Inc. (NASDAQ:AZTA) today reported financial results for the third quarter ended June 30, 2022. Quarter Ended Dollars in millions, except per share data June 30,  March 31,  June 30,  Change 2022 2022 2021 Prior Qtr. Prior Yr. Revenue from Continuing Operations $ 133 $ 146 $ 129 (9) % 3 % Life Sciences Products $ 47 $ 54 $ 49 (12) % (3) % Life Sciences Services $ 85 $ 92 $ 80 (7) % 6 % Diluted EPS Continuing Operations $ (0.09) $ (0.02) $ (0.02) nm nm Diluted EPS Total $ (0.13) $ 28.28 $ 0.53 nm nm Non-GAAP Diluted EPS Continuing Operations $ 0.12 $ 0.12 $ 0.10 0 % 14 % Adjusted EBITDA Continuing Operations $ 14 $ 19 $ 19 (29) % (26) % M

      8/9/22 4:20:00 PM ET
      $AZTA
      $BRKS
      Industrial Machinery/Components
      Technology
    • Azenta Announces Agreement to Acquire B Medical Systems

      Enhances Azenta's Leadership Position in Cold Chain Solutions and End-to-End Sample Management CHELMSFORD, Mass., Aug. 8, 2022 /PRNewswire/ -- Azenta, Inc. (NASDAQ:AZTA) today announced that it has entered into a definitive agreement to acquire B Medical Systems S.á r.l and its subsidiaries ("B Medical"), a market leader in temperature-controlled storage and transportation solutions that enables the delivery of life-saving treatments across the globe. The cash purchase price to be paid at closing will be approximately €410 million. Additional cash consideration, up to €50 million, may be paid upon achievement of certain future performance milestones. The transaction is expected to close in O

      8/8/22 4:05:00 PM ET
      $AZTA
      $BRKS
      Industrial Machinery/Components
      Technology

    $BRKS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more

    $BRKS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • SEC Form SC 13G filed

      SC 13G - Brooks Automation, Inc. (0000933974) (Subject)

      2/11/21 3:13:09 PM ET
      $BRKS
      Industrial Machinery/Components
      Technology
    • SEC Form SC 13G/A filed

      SC 13G/A - Brooks Automation, Inc. (0000933974) (Subject)

      2/10/21 10:39:37 AM ET
      $BRKS
      Industrial Machinery/Components
      Technology
    • Needham reiterated coverage on Brooks Automation with a new price target

      Needham reiterated coverage of Brooks Automation with a rating of Buy and set a new price target of $155.00 from $139.00 previously

      11/17/21 6:08:56 AM ET
      $BRKS
      Industrial Machinery/Components
      Technology
    • Keybanc reiterated coverage on Brooks Automation with a new price target

      Keybanc reiterated coverage of Brooks Automation with a rating of Overweight and set a new price target of $132.00 from $146.00 previously

      11/17/21 4:42:32 AM ET
      $BRKS
      Industrial Machinery/Components
      Technology
    • Citigroup reiterated coverage on Brooks Automation with a new price target

      Citigroup reiterated coverage of Brooks Automation with a rating of Neutral and set a new price target of $120.00 from $100.00 previously

      11/11/21 10:07:00 AM ET
      $BRKS
      Industrial Machinery/Components
      Technology

    $BRKS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4: Jarzynka David sold $1,228,883 worth of shares (10,216 units at $120.29), decreasing direct ownership by 18% to 46,315 units

      4 - Brooks Automation, Inc. (0000933974) (Issuer)

      11/22/21 4:16:54 PM ET
      $BRKS
      Industrial Machinery/Components
      Technology
    • SEC Form 4: Joseph Jason sold $1,036,933 worth of shares (8,694 units at $119.27), decreasing direct ownership by 9% to 89,850 units to cover withholding tax

      4 - Brooks Automation, Inc. (0000933974) (Issuer)

      11/19/21 4:16:49 PM ET
      $BRKS
      Industrial Machinery/Components
      Technology
    • SEC Form 4: Vacha Robin sold $1,831,384 worth of shares (15,368 units at $119.17), decreasing direct ownership by 40% to 22,932 units (tax withholding)

      4 - Brooks Automation, Inc. (0000933974) (Issuer)

      11/19/21 4:15:33 PM ET
      $BRKS
      Industrial Machinery/Components
      Technology

    $BRKS
    SEC Filings

    See more
    • Brooks Automation, Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits

      8-K - Azenta, Inc. (0000933974) (Filer)

      12/1/21 8:15:39 AM ET
      $BRKS
      Industrial Machinery/Components
      Technology
    • SEC Form 10-K filed by Brooks Automation, Inc.

      10-K - Brooks Automation, Inc. (0000933974) (Filer)

      11/24/21 9:17:52 AM ET
      $BRKS
      Industrial Machinery/Components
      Technology
    • Brooks Automation, Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - Brooks Automation, Inc. (0000933974) (Filer)

      11/10/21 4:35:48 PM ET
      $BRKS
      Industrial Machinery/Components
      Technology